Maquet Cardiovascular LLC
Maquet recalls intra-aortic balloon pumps on shutdown risk
Getinge posts H1 sales growth, profits slide 33%
Getinge (PINK:GETI B) reported sales growth for the 1st half of the year, but said profits were down by nearly a third.
The Swedish healthcare firm, which owns medical device company Maquet, posted profits of roughly $95.6 million, or 40¢ per share, on sales of $1.74 billion for the 6 months ended June 30.
Maquet acquires LAAx and its TigerPaw II heart implant
Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular said it bought LAAx Inc and its TigerPaw II heart implant for an undisclosed amount.
Maquet’s Class I ventilator battery recall affects 90k units
A Class I recall, reserved for serious patient harm, was issued over battery units produced by Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular.
Maquet lands FDA nod for Air-Band catheter device
Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular racked up a win for another of its devices designed to close artery incisions for catheters after the FDA cleared its Air-Band radial compression device for the U.S. market.
The device is designed to help seal the radial artery after a catheterization procedure, in which the catheter is threaded into the heart via a radial artery incision in the wrist.
Maquet lands FDA and CE Mark wins for larger-volume IAB catheter
Maquet Cardiovascular landed FDA 510(k) clearance and CE Mark approval in the European Union for a new version of its intra-aortic balloon catheters, the Sensation Plus 7.5Fr 40cc.
The larger-volume fiber optic IAB catheter, designed for smaller patients between 5’0" and 5’4", will be on the market in the U.S. and E.U. in October, according to a press release.
Shock study calls into question decades of intra-aortic balloon counter-pulsation
Physicians and medical boards may have to reconsider decades of cardiogenic shock treatment after the highly anticipated IABP-Shock study found no significant benefit in using intra-aortic balloon pump therapy in heart attack patients.
GE Healthcare ventilator recall gets Class I status from the FDA
GE Healthcare (NYSE:GE) landed Class I status for its Aestiva/5 7900 ventilator recall, a category the FDA reserves for the most serious issues "in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death."
Novation details group buys for capital equipment
Novation said members of VHA Inc., UHC and Provista LLC can nab discounts of up to 71% on capital equipment fromJuly through September.
The group purchasing organization said the discounts include medical devices ranging from centrifuges and patient beds to CT scanners and nuclear medicine equipment.